Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mosedipimod by Enzychem Lifesciences for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Mosedipimod is under clinical development by Enzychem Lifesciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Data Insights
Mosedipimod by Enzychem Lifesciences for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Mosedipimod is under clinical development by Enzychem Lifesciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute...